IL6 and Hypoglycemia: Among these three concentrations, 25% PF127 gel formulation was found to be the best one that prolonged the in vitro and in vivo release, showed greater efficacy to induce hypoglycemia and inhibited IL-1β-stimulated production of IL-6 in wistar rats when compared with that of IL-1Ra solution.